Mariarosaria Miranda: I Successfully Defended my PhD!
Mariarosaria Miranda, PhD in Immunohematology at Sanquine, shared on LinkedIn:
”I am excited to share that on 06/11/25, I successfully defended my PhD!
My thesis, “A stranger no more: re-educating the immune system to FVIII in hemophilia A,” explored the development of inhibitory antibodies against factor VIII (FVIII), a major challenge in hemophilia A treatment, and how we can modulate the immune system toward tolerance.
In brief, my work investigated several complementary strategies to better understand and modulate the immune response to FVIII:
• Mapping FVIII peptide presentation on HLA-DP molecules (especially HLA-DP4) to identify immunodominant peptides that could inform future tolerance-inducing therapies.
• Using red blood cells (RBCs) as delivery platforms for FVIII–TAT fusion peptides, showing efficient uptake by immune cells and highlighting RBCs as a promising carrier system.
• Engineering FVIII–Annexin A5 fusion proteins, exploiting apoptotic clearance pathways to promote tolerogenic antigen presentation.
• Studying FVIII-containing immune complexes, pointing to the inhibitory receptor FcγRIIb as a potential target to dampen dendritic cell activation.
• Characterizing anti-FVIII antibodies in a large patient cohort to clarify the role of non-neutralizing antibodies as markers of inhibitor risk or immune modulation.
Together, these findings contribute to a deeper understanding of FVIII immunogenicity and open multiple avenues for developing targeted immune tolerance strategies in hemophilia A.
My heartfelt thanks to my promoters, Jan Voorberg and Karin Fijnvandraat, and to my supervisor Maartje van den Biggelaar, for their guidance, encouragement, and trust throughout this journey.
A special thank you to the EDUC8 consortium and to the MSCA for supporting my research and providing an inspiring international training environment.
I’m grateful for everyone who has been part of this chapter, colleagues, collaborators, friends, and family.
Exciting news ahead, stay tuned!”
Stay updated with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?